ERYTHEMATOTELANGIECTATIC ROSACEA

ERYTHEMATOTELANGIECTATIC ROSACEA was reported 23 times

ERYTHEMATOTELANGIECTATIC ROSACEA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-17A Antagonist [EPC] 9 0.0002
1 Anti-IgE [EPC] 8 0.0001
2 Antirheumatic Agent [EPC] 9 0.0001
3 Non-Standardized Plant Allergenic Extract [EPC] 1 0.0001
4 Carbonic Anhydrase Inhibitor [EPC] 1 0.0000
5 PCSK9 Inhibitor [EPC] 1 0.0000
6 Folate Analog Metabolic Inhibitor [EPC] 14 0.0000
7 Nitroimidazole Antimicrobial [EPC] 2 0.0000
8 Thiazide-like Diuretic [EPC] 1 0.0000
9 Vitamin D [EPC] 7 0.0000
10 Vitamin B12 [EPC] 7 0.0000
11 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
12 Methylxanthine [EPC] 1 0.0000
13 Vitamin C [EPC] 7 0.0000
14 Non-Standardized Chemical Allergen [EPC] 1 0.0000
15 Arteriolar Vasodilator [EPC] 1 0.0000
16 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
17 Dihydropyridine Calcium Channel Blocker [EPC] 4 0.0000
18 Central Nervous System Stimulant [EPC] 1 0.0000
19 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
20 Purine Antimetabolite [EPC] 1 0.0000
21 Acetylcholine Release Inhibitor [EPC] 1 0.0000
22 Aminosalicylate [EPC] 1 0.0000
23 Azole Antifungal [EPC] 1 0.0000
24 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
25 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
26 Proton Pump Inhibitor [EPC] 2 0.0000
27 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
28 Platelet Aggregation Inhibitor [EPC] 1 0.0000
29 Corticosteroid [EPC] 2 0.0000
30 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000